Search

everythinglearnresearchcommunity

for

Search:↓

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

High-dose vitamin A and E with zinc improved blood sugar control and insulin function in diabetics, but may cause hair loss.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Premature hair greying may indicate a higher risk of metabolic problems.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.